Design and characterization of BSA-mycophenolic acid nanocomplexes: Antiviral activity exploration.

The interactions between bovine serum albumin (BSA) and mycophenolic acid (MPA) were investigated in silico through molecular docking and in vitro, using fluorescence spectroscopy. Dynamic light scattering and scanning electron microscopy were used to figure out the structure of MPA-Complex (MPA-C). The binding affinity between MPA and BSA was determined, yielding a Kd value of (12.0 ± 0.7) μM, and establishing a distance of 17 Å between the BSA and MPA molecules. The presence of MPA prompted protein aggregation, leading to the formation of MPA-C. The cytotoxicity of MPA-C and its ability to fight Junín virus (JUNV) were tested in A549 and Vero cell lines. It was found that treating infected cells with MPA-C decreased the JUNV yield and was more effective than free MPA in both cell line models for prolonged time treatments. Our results represent the first report of the antiviral activity of this type of BSA-MPA complex against JUNV, as assessed in cell culture model systems. MPA-C shows promise as a candidate for drug formulation against human pathogenic arenaviruses.
Competing Interests: Declaration of competing interest Dr. Claudia S. Sepúlveda reports financial support was provided by National Scientific and Technical Research Council. Dr. Claudia S. Sepúlveda reports financial support was provided by National Agency for the Promotion of Research Technological Development and Innovation. Dr. Claudia S. Sepúlveda reports equipment, drugs, or supplies was provided by Novartis Pharmaceuticals Corporation. Dr. Elsa B. Damonte reports financial support was provided by University of Buenos Aires.
(Copyright © 2024 Elsevier B.V. All rights reserved.)